Potentiation by thyroxine of interferon-γ-induced antiviral state requires PKA and PKC activities

American Journal of Physiology - Cell Physiology

Volumn 271, Issue 4 40-4, 1996, Pages

  Lin, Hung Yun ^b   Thacore, Harshad R ^b   Davis, Faith B ^b   Davis, Paul J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

antiviral action; protein kinase A; protein kinase C; thyroid hormone

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 8 BROMO CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; KT 5720; MIDOSTAURIN; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE C INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE INHIBITOR; RECOMBINANT GAMMA INTERFERON; STAUROSPORINE; THYROXINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; FIBROBLAST CULTURE; HELA CELL; HORMONE ACTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VIRUS CULTURE;

ANIMALIA;

EID: 0029859219     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1996.271.4.c1256     Document Type: Article

References (28)

1. Alter, C. A., M. Amagasu, K. Shah, Y. C. Jolly, C. Major, and B. A. Wolf. U-73122 does not specifically inhibit phospholipase C in rat pancreatic islets and insulin-secreting β-cell lines. Life Sci. 54: 107-112, 1994.
2. Caravatti, G., T. Meyer, A. Fredenhagen, U. Trinks, H. Mett, and D. Fabbro. Inhibitory activity and selectivity of staurosporine derivatives towards protein kinase C. Bioorg. Med. Chem. Lett. 4: 399-404, 1994.
3. Davis, P. J. Cellular actions of thyroid hormones. In: The Thyroid, edited by L. E. Braverman and R. D. Utiger. Philadelphia, PA: Lippincott, 1991, p. 190-203.
4. Farwell, A. P., D. J. DiBenedetto, and J. L. Leonard. Thyroxine targets different pathways of internalization of type II iodothyronine 5′-deiodinase in astrocytes. J. Biol. Chem. 268: 5055-5062, 1993.
5. Gupta, S. L. Regulation of interferon-inducible genes. In: Interferon: Principles and Medical Applications, edited by S. Baron, D. H. Coppenhaver, F. Dianzani, W. R. Fleischmann, Jr., T. K. Hughes, Jr., G. R. Kumpel, D. W. Niesel, G. J. Stanton, and S. K. Tyring. Galveston: Univ. of Texas Medical Branch at Galveston, 1992, p. 193-213.
6. Harris, D. R., W. L. Green, and W. Craelius. Acute thyroid hormone promotes slow inactivation of sodium current in neonatal cardiac myocytes. Biochim. Biophys. Acta 1045: 175-181, 1991.
7. Kase, H., K. Iwahashi, S. Nakanishi,Y. Matsuda, K. Yamada, M. Takahashi, C. Murakata, A. Sato, and M. Kaneko. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142: 436-440, 1987.
8. Lawrence, W. D., M. Schoenl, and P. J. Davis. Stimulation in vitro of rabbit erythrocyte cytosol phospholipid-dependent protein kinase activity. A novel action of thyroid hormone. J. Biol. Chem. 264: 4766-4768, 1989.
9. Lin, H.-Y., H. R. Thacore, F. B. Davis, and P. J. Davis. Thyroid hormone analogues potentiate the antiviral action of interferon-γ by two mechanisms. J. Cell. Physiol. 167: 269-276, 1996.
10. Lin, H.-Y., H. R. Thacore, P. J. Davis, and F. B. Davis. Thyroid hormone potentiates the antiviral action of interferon-gamma in cultured human cells. J. Clin. Endocrinol. Metab. 79: 62-65, 1994.
11. Newton, A. C. Protein kinase C: structure, function, and regulation. J. Biol. Chem. 270: 28495-28498, 1995.
12. Nishizuka, Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science Wash. DC 258: 607-614, 1992.
13. Oppenheimer, J. H. Thyroid hormone action at the molecular level. In: The Thyroid, edited by L. E. Braverman and R. D. Utiger. Philadelphia, PA: Lippincott, 1991, p. 204-224.
14. Provinciali, M., and N. Fabris. Modulation of lymphoid cell sensitivity to interferon by thyroid hormone. J. Endocrinol. Invest. 13: 187-191, 1990.
15. Provinciali, M., M. Muzzioli, G. DiStefano, and N. Fabris. Recovery of spleen cell natural killer activity by thyroid hormone treatment in old mice. Nat. Immun. Cell Growth Regul. 10: 226-236, 1991.
16. Provinciali, M., M. Muzzioli, and N. Fabris. Thyroxine-dependent modulation of natural killer activity. J. Exp. Pathol. 3: 617-622, 1987.
17. Samuels, H. H., F. Stanley, and J. Casanova. Depletion of L-3,5,3′-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105: 80-85, 1979.
18. Sen, G. C., and P. Lengyel. The interferon system: a bird's eye view of its biochemistry. J. Biol. Chem. 267: 5017-5020, 1992.
19. Shuai, K., G. R. Stark, I. M. Kerr, and J. E. Darnell, Jr. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-γ. Science Wash. DC 261: 1744-1746, 1993.
20. Siegrist-Kaiser, C. A., C. Juge-Aubry, M. P. Tranter, D. M. Ekenbarger, and J. L. Leonard. Thyroxine-dependent modulation of actin polymerization in cultured astrocytes. A novel, extranuclear action of thyroid hormone. J. Biol. Chem. 265: 5296-5302, 1990.
21. 3 rat pituitary cells. Endocrinology 131: 1883-1888, 1992.
22. Staeheli, P. Interferon-induced proteins and the antiviral state. Adv. Virus Res. 38: 147-200, 1990.
23. Stark, G. R., and I. M. Kerr. Interferon-dependent signaling pathways: DNA elements, transcription factors, mutations and effects of viral proteins. J. Interferon Res. 12: 147-151, 1992.
24. Stein-Streilen, J., M. Zakarija, M. Papic, and J. M. McKenzie. Hyperthyroxinemic mice have reduced natural killer cell activity. J. Immunol. 139: 2502-2507, 1987.
25. Topliss, D. J, G. H. Scholz, E. Kolliniatis, J. W. Barlow, and J. R. S. Stockigt. Influence of calmodulin antagonists and calcium channel blockers on triiodothyronine uptake by rat hepatoma and myoblast cell lines. Metab. Clin. Exp. 42: 376-380, 1993.
26. Weinstein, S. P., J. Watts, P. N. Graves, and R. S. Haber. Stimulation of glucose transport by thyroid hormone in ARL15 cells: increased abundance of glucose transporter protein and messenger ribonucleic acid. Endocrinology 126: 1421-1429, 1990.
27. Winship, T. R., and H. R. Thacore. Inhibition of vesicular stomatitis virus defective-interfering particle synthesis by Shope fibroma virus. Virology 93: 515-526, 1979.
28. Youngner, J. S., H. R. Thacore, and M. E. Kelly. Sensitivity of ribonucleic acid and deoxyribonucleic acid viruses to different species of interferon in cell culture. J. Virol. 10: 171-178, 1972.